Clinical Trial Update: Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 safety and tolerability study of T-1301 capsules for advanced solid tumors and lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• T-1301

Snippet

Sponsor: Taivex Therapeutics Corporation | Conditions: Advanced Solid Tumor, Lymphoma | Phase 1 | Status: RECRUITING